drugset
drugset / Trial / NCT04002895

What the Body Does to Foliglurax in Healthy Volunteers

NCT04002895 ↗

Phase 1 Completed 6 enrolled H. Lundbeck A/S
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates how the body takes up and gets rid of foliglurax after swallowing a liquid dose.

Timeline

Start
2019-06-27
Primary completion
2019-08-01
Completion
2019-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Foliglurax Small molecule 80 mg Oral

Indications

No indication recorded.